Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Aug;316(2):e243412.
doi: 10.1148/radiol.243412.

MRI-based Ovarian Lesion Classification via a Foundation Segmentation Model and Multimodal Analysis: A Multicenter Study

Affiliations
Multicenter Study

MRI-based Ovarian Lesion Classification via a Foundation Segmentation Model and Multimodal Analysis: A Multicenter Study

Wen-Chi Hsu et al. Radiology. 2025 Aug.

Abstract

Background Artificial intelligence may enhance diagnostic accuracy in classifying ovarian lesions on MRI scans; however, its applicability across diverse datasets is uncertain. Purpose To develop an efficient, generalizable pipeline for MRI-based ovarian lesion characterization. Materials and Methods In this retrospective study, multiparametric MRI datasets of patients with ovarian lesions from a primary institution (January 2008 to January 2019) and two external institutions (January 2010 to October 2020) were analyzed. Lesions were automatically segmented using Meta's Segment Anything Model (SAM). A DenseNet-121 deep learning (DL) model incorporating both imaging and clinical data was then trained and validated externally for ovarian lesion classification. Lesions were evaluated by radiologists using the Ovarian-Adnexal Reporting and Data System for MRI and subjective assessment, classifying them as benign or malignant. The classification performances of the DL model and radiologists were compared using the DeLong test. Results The primary dataset included 534 lesions from 448 women (mean age, 52 years ± 15 [SD]) from institution A (United States), whereas the external datasets included 58 lesions from 55 women (mean age, 51 years ± 19) from institution B (United States) and 29 lesions from 29 women (mean age, 49 years ± 10) from institution C (Taiwan). SAM-assisted segmentation had a Dice coefficient of 0.86-0.88, reducing the processing time per lesion by 4 minutes compared with manual segmentation. The DL classification model achieved an area under the receiver operating characteristic curve (AUC) of 0.85 (95% CI: 0.85, 0.85) on the internal test and 0.79 (95% CI: 0.79, 0.79 and 0.78, 0.79) across both external datasets with SAM-segmented images, comparable with the radiologists' performance (AUC: 0.84-0.93; all P > .05). Conclusion These results describe an accurate, efficient pipeline that integrates SAM with DL-based classification for differentiating malignant from benign ovarian lesions on MRI scans. It reduced segmentation time and achieved classification performance comparable with that of radiologists. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Bhayana and Wang in this issue.

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflicts of interest: W.C.H. No relevant relationships. Y.W. No relevant relationships. Y.F.W. No relevant relationships. R.C. No relevant relationships. S.A. No relevant relationships. J.L. No relevant relationships. S.V. No relevant relationships. V.S. No relevant relationships. M.I. No relevant relationships. J.S.C. No relevant relationships. G.Z. Trainee editorial board member of Radiology: Imaging Cancer since July 2025. Y.C. No relevant relationships. J.P.L. No relevant relationships. K.O. Grant from the National Institutes of Health and National Institute of Neurological Disorders and Stroke (R01NS126549) Gates Venture; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Kyoto University National Institute for Quantum Science and Technology; Annual Meeting Program Committee, International Society for Magnetic Resonance in Medicine. A.Z. No relevant relationships. R.C.W. No relevant relationships. P.J.L.Z. No relevant relationships. J.W. No relevant relationships. Z.J. No relevant relationships. I.R.K. No relevant relationships. G.L. No relevant relationships. H.X.B. Grants from the National Institutes of Health and National Science Foundation.

References

    1. Bray F , Laversanne M , Sung H , et al . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries . CA Cancer J Clin 2024. ; 74 ( 3 ): 229 – 263 . - PubMed
    1. Torre LA , Trabert B , DeSantis CE , et al . Ovarian cancer statistics, 2018 . CA Cancer J Clin 2018. ; 68 ( 4 ): 284 – 296 . - PMC - PubMed
    1. Armstrong DK , Alvarez RD , Bakkum-Gamez JN , et al . Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology . J Natl Compr Canc Netw 2021. ; 19 ( 2 ): 191 – 226 . - PubMed
    1. Sadowski EA , Rockall AG , Maturen KE , Robbins JB , Thomassin-Naggara I . Adnexal lesions: Imaging strategies for ultrasound and MR imaging . Diagn Interv Imaging 2019. ; 100 ( 10 ): 635 – 646 . - PubMed
    1. Vargas HA , Barrett T , Sala E . MRI of ovarian masses . J Magn Reson Imaging 2013. ; 37 ( 2 ): 265 – 281 . - PubMed

Publication types

LinkOut - more resources